Latest Period
Q4 2025
Security Snapshot
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) Institutional Ownership
CUSIP: 282644400
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
26
Shares (Excl. Options)
256,881
Price
$8.64
Save this security research path
Keep this CUSIP in your research flow, then return after the next filing cycle to check what changed.
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- EKSO on Nasdaq
- Shares outstanding
- 2,914,374
- Price per share
- $10.65
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 256,881
- Total reported value
- $2,219,848
- % of total 13F portfolios
- 0%
- Share change
- -161,400
- Value change
- -$866,809
- Number of holders
- 26
- Price from insider filings
- $10.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share is tracked under CUSIP 282644400.
- 26 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 26 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $2,219,848 to $1,015,275.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 282644400?
CUSIP 282644400 identifies EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 282644400:
Significant Owners of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ASHER DANIEL | 17% | +78% | $5,866,980 | +$3,081,510 | 677,723 | +111% | DANIEL ASHER | 22 Jan 2026 |
| ARMISTICE CAPITAL, LLC | 10% | $2,442,715 | 291,146 | Armistice Capital, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 26 institutional investors reported holding 256,881 shares of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO). This represents 8.8% of the company’s total 2,914,374 outstanding shares.